S.Y. Gil, et al. (2013) have shown that Clusterin is able to regulate energy metabolism and body weight through LRP2 and enhance leptin binding to the leptin receptor, thereby suppressing appetite, using AdipoGen's Clusterin (secretory form) (human) (rec.).
AdipoGen's famous anti-NLRP3/NALP3, mAb (Cryo-2) was published to work in ICC (Komune et al. 2011), IHC (Heneka et al. 2012) and IP (Py et al. 2012).